Standard BioTools Free Cash Flow 2010-2024 | LAB

Standard BioTools free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.

Standard BioTools Free Cash Flow 2010-2024 | LAB

Standard BioTools free cash flow from 2010 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$37.9B
Tempus AI (TEM)$9B
Hims & Hers Health (HIMS)$8.1B
Inspire Medical Systems (INSP)$5.8B
IRhythm Technologies (IRTC)$3.4B
Privia Health (PRVA)$2.7B
Enovis (ENOV)$2.7B
Azenta (AZTA)$2.5B
Clover Health Investments (CLOV)$2.2B
Omnicell (OMCL)$2.1B
Schrodinger (SDGR)$1.8B
10x Genomics (TXG)$1.8B
Phreesia (PHR)$1.7B
Butterfly Network (BFLY)$850M
Talkspace (TALK)$524M
Fulgent Genetics (FLGT)$509M
TruBridge (TBRG)$370M
Nyxoah SA (NYXH)$368M
Health Catalyst (HCAT)$343M
SOPHiA GENETICS SA (SOPH)$229M
Pulmonx (LUNG)$224M
American Well (AMWL)$165M
MDxHealth SA (MDXH)$90M
EUDA Health Holdings (EUDA)$87M
P3 Health Partners (PIII)$65M
HeartBeam (BEAT)$64M
CareCloud (CCLD)$56M
111 (YI)$50M
SHL Telemedicine (SHLT)$47M
Outset Medical (OM)$43M